November 2

Urodynamix Announces Appointment of New Director and Issuance of Stock Options

October 4

Urodynamix Begins Enrollment for NIRS Study of Urinary Incontinence in Women

September 26

Urodynamix Initiates US Clinical Study of NIRS Technology

September 13

Urodynamix Announces Management Change

July 31

Urodynamix Reports Successful Results for NIRS in Stress Urinary Incontinence and Over Active Bladder in Women

July 26

Urodynamix Successfully Raises $2,419,325

July 5

Urodynamix reports successful results of NIRS in Prostate Study

June 30

Urodynamix receives TSX Venture approval for warrant incentive program

June 21

MDX Changes Company Name to Urodynamix Technologies Ltd. to Reflect New Focus on Urology Products and Trading Symbol to URO Effective June 21, 2006

June 9

MDX AGM Summary MDX to Change Company Name to Urodynamix Technologies Ltd. and Trading Symbol to URO

May 23

MDX Completes Patient Enrollment for CIHR Study of NIRS Technology

May 17

MDX Licenses AVID Technology to Japanese Company

April 10

MDX to Develop a Non-Invasive Urodynamics Device

February 22

MDX Begins NIRS Urodynamics Clinical Study

February 15

MDX Medical Hires VP Marketing & Communication